ClinicalTrials.Veeva

Menu

Sacral Neuromodulation & Urodynamics

U

Universiteit Antwerpen

Status

Unknown

Conditions

Non-obstructive Urinary Retention
Overactive Bladder

Treatments

Diagnostic Test: urodynamics

Study type

Observational

Funder types

Other

Identifiers

NCT03614767
17/30334

Details and patient eligibility

About

In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR).

Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Overactive bladder
  • Non-obstructive urinary retention

Exclusion criteria

  • Neurogenica disorder (e.g. cerebrovascular accident, spinal cord injury)

Trial design

100 participants in 2 patient groups

Successes
Description:
Patients with \>50% improvement during test procedure of sacral neuromodulation.
Treatment:
Diagnostic Test: urodynamics
Failures
Description:
Patients with \<50% improvement during test procedure of sacral neuromodulation.
Treatment:
Diagnostic Test: urodynamics

Trial contacts and locations

1

Loading...

Central trial contact

Stefan De Wachter, MD PhD FEBU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems